title: Editorial comment: Reduction of oxidative stress: a new indication for acetylsalicylic acid in coronary artery bypass surgery.
authors.affiliation: Heart Center, Cardiology and Angiology I, Freiburg University, Freiburg, Germany. philipp.diehl@universitaets-herzzentrum.de
authors.forename: Philipp
authors.initials: P
authors.lastname: Diehl
authors.forename: Christoph
authors.initials: C
authors.lastname: Olivier
authors.forename: Christoph
authors.initials: C
authors.lastname: Bode
authors.forename: Martin
authors.initials: M
authors.lastname: Moser
mesh_terms: D001241:Aspirin / Q000008:administration & dosage*; D001026:Coronary Artery Bypass / Q000379:methods*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*
chemical_list: D001241:Aspirin